Page last updated: 2024-11-11

antithiamine factor

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

antithiamine factor: from mustard seed; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5321318
CHEMBL ID146713
CHEBI ID194845
SCHEMBL ID9908304
MeSH IDM0049232

Synonyms (30)

Synonym
CHEMBL146713
methyl sinapate
BMSE000589 ,
3,5-dimethoxy-4-hydroxy cinnamic acid methyl ester
antithiamine factor
BMSE010221
methyl (3,5-dimethoxy-4-hydroxy)cinnamate
CHEBI:194845
methyl-sinapate
methyl (e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate
methyl 3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate
AC1NT0EV ,
20733-94-2
AKOS015999011
SCHEMBL9908304
methyl 3-(4-hydroxy-3,5-dimethoxyphenyl)acrylate
2-propenoic acid, 3-(4-hydroxy-3,5-dimethoxyphenyl)-, methyl ester
cinnamic acid, 4-hydroxy-3,5-dimethoxy-, methyl ester
JHLPYWLKSLVYOI-SNAWJCMRSA-N
methyl 4-hydroxy-3,5-dimethoxycinnamate
sinapic acid methyl ester
methyl (e)-3-(4-hydroxy-3,5-dimethoxy-phenyl)prop-2-enoate
methyl (e)-3-(4-hydroxy-3,5-dimethoxyphenyl)acrylate
methyl 4-hydroxy-3,5-dimethoxycinnamate; sinapic acid methyl ester
Y14683
A879467
BS-22030
methylsinapate
EN300-7409441
AKOS040760554
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxycinnamic acidAny member of the class of cinnamic acids carrying one or more hydroxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Substance-P receptorCavia porcellus (domestic guinea pig)CD93.00000.90004.50009.8000AID144377
Quinone oxidoreductaseMus musculus (house mouse)CD93.00000.20002.74219.8000AID144377
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID144377Ability to induce NAD(P)H quinone reductase activity in cultured Hepa 1c1c7 murine hepatoma cells.1998Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers.
AID354751Trypanocidal activity against Trypanosoma cruzi trypomastigote assessed as lysis of trypomastigotes at 250 ug/mL after 24 hrs relative to control1996Journal of natural products, Apr, Volume: 59, Issue:4
Pessoine and spinosine, two catecholic berbines from Annona spinescens.
AID1819013Inhibition of 5-LO in A23187-stimulated human HEK293 cells assessed as reduction in 5-LO product level at 1 uM preincubated for 5 mins followed by A23187, arachidonic acid addition and measured after 15 mins by RP-HPLC analysis relative to control2022Journal of natural products, 01-28, Volume: 85, Issue:1
Structure-Activity Relationship Studies of New Sinapic Acid Phenethyl Ester Analogues Targeting the Biosynthesis of 5-Lipoxygenase Products: The Role of Phenolic Moiety, Ester Function, and Bioisosterism.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (43.75)18.7374
1990's2 (12.50)18.2507
2000's1 (6.25)29.6817
2010's5 (31.25)24.3611
2020's1 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.31 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]